Bicocca Open Archive

Logo unimib boa
CRISTOFERI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.590
AS - Asia 4.311
EU - Europa 3.601
SA - Sud America 698
AF - Africa 116
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 14.321
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.468
SG - Singapore 1.467
IT - Italia 1.042
CN - Cina 767
VN - Vietnam 757
HK - Hong Kong 608
RU - Federazione Russa 554
BR - Brasile 516
DE - Germania 479
SE - Svezia 453
IE - Irlanda 266
GB - Regno Unito 222
IN - India 154
FR - Francia 153
KR - Corea 89
AR - Argentina 75
ID - Indonesia 64
FI - Finlandia 63
BD - Bangladesh 59
NL - Olanda 59
CA - Canada 55
TR - Turchia 50
ES - Italia 49
CH - Svizzera 46
IQ - Iraq 46
UA - Ucraina 39
ZA - Sudafrica 37
MX - Messico 35
PK - Pakistan 34
AT - Austria 33
MY - Malesia 32
PL - Polonia 29
JP - Giappone 27
PH - Filippine 26
EC - Ecuador 25
DK - Danimarca 23
SA - Arabia Saudita 23
VE - Venezuela 22
CO - Colombia 21
UZ - Uzbekistan 19
BE - Belgio 17
IL - Israele 14
CL - Cile 13
LT - Lituania 13
MA - Marocco 13
PY - Paraguay 13
KE - Kenya 12
EG - Egitto 11
ET - Etiopia 10
JO - Giordania 10
PT - Portogallo 9
TN - Tunisia 9
TW - Taiwan 8
AZ - Azerbaigian 7
GR - Grecia 7
RS - Serbia 7
CZ - Repubblica Ceca 6
JM - Giamaica 6
NO - Norvegia 6
SK - Slovacchia (Repubblica Slovacca) 6
SY - Repubblica araba siriana 6
BO - Bolivia 5
DZ - Algeria 5
PA - Panama 5
KZ - Kazakistan 4
MM - Myanmar 4
NP - Nepal 4
PE - Perù 4
RO - Romania 4
TT - Trinidad e Tobago 4
BG - Bulgaria 3
CR - Costa Rica 3
HN - Honduras 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
MU - Mauritius 3
OM - Oman 3
PS - Palestinian Territory 3
SN - Senegal 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GD - Grenada 2
GE - Georgia 2
GH - Ghana 2
IR - Iran 2
KH - Cambogia 2
MO - Macao, regione amministrativa speciale della Cina 2
NI - Nicaragua 2
TH - Thailandia 2
TJ - Tagikistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BB - Barbados 1
BF - Burkina Faso 1
Totale 14.295
Salva come PNG Salva come JPEG
Città #
Singapore 906
Ann Arbor 862
Hong Kong 587
Ashburn 510
San Jose 492
Frankfurt am Main 369
Milan 336
Dublin 252
Fairfield 231
Chicago 223
Chandler 220
Ho Chi Minh City 211
New York 207
Wilmington 181
Hanoi 178
Los Angeles 173
Hefei 153
Beijing 131
Santa Clara 117
Dallas 108
The Dalles 108
Woodbridge 104
London 99
Seattle 97
Houston 92
Seoul 84
Cambridge 81
Princeton 72
Lauterbourg 71
Rome 68
Shanghai 68
Buffalo 61
São Paulo 58
Council Bluffs 51
Dearborn 44
Moscow 44
Jakarta 43
Helsinki 42
Zurich 42
Lawrence 35
Orem 33
Munich 32
Florence 31
Altamura 28
Monza 28
Boardman 27
Haiphong 26
Tokyo 25
Warsaw 25
Da Nang 24
Denver 24
San Diego 21
Chennai 20
Johannesburg 20
Pune 20
Rio de Janeiro 19
Ninh Bình 18
Nuremberg 18
Turin 18
Biên Hòa 17
Can Tho 17
Mumbai 17
Tashkent 17
Atlanta 16
Brussels 16
Nanjing 16
Paris 16
Penang 16
Poplar 16
Montreal 15
New Delhi 15
Baghdad 14
Brooklyn 14
Jacksonville 14
Salt Lake City 14
Toronto 14
Vienna 14
Elk Grove Village 13
Stockholm 13
Andover 12
Bologna 12
Hải Dương 12
Istanbul 12
Phoenix 12
Amsterdam 11
Boston 11
Campinas 11
Guarulhos 11
Ha Long 11
Lappeenranta 11
Mexico City 11
Modena 11
Nairobi 11
Bari 10
Cairo 10
Jeddah 10
Manchester 10
Naples 10
Columbus 9
Curitiba 9
Totale 8.799
Salva come PNG Salva come JPEG
Nome #
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 576
Quality of life in patients with primary biliary cholangitis: a cross-geographical comparison 405
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 377
Endocrinology and Metabolic Diseases (Including Diabetes) 330
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 329
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 329
Risk stratification in primary sclerosing cholangitis 323
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 322
Precision medicine in primary biliary cholangitis 317
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 310
FRI-008-Incidence, prevalence and mortality of primary sclerosing cholangitis in Italy: A population-based study 308
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 307
A NOVEL MACHINE-LEARNING, COMMON VARIANTS-BASED APPROACH TO PREDICT PRIMARY BILIARY CHOLANGITIS 291
New Therapeutic Targets in Autoimmune Cholangiopathies 280
Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group 279
THU-010-Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 270
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 268
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 265
Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 253
Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies 247
RADIOLOGY-BASED BIOMARKERS DISCOVERY IN PRIMARY SCLEROSING CHOLANGITIS: FROM RISK STRATIFICATION TO THE EVALUATION OF TREATMENT BENEFIT 245
Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets 241
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 239
Prognostic models in primary biliary cholangitis 231
Artificial intelligence for precision medicine in autoimmune liver disease 227
FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 225
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 224
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain? 223
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 223
Improving predictive accuracy in primary biliary cholangitis: A new genetic risk score 222
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 219
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study 217
Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement 212
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis 208
COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy 206
X marks the spot in autoimmunity 204
Primary sclerosing cholangitis: Burden of disease and mortality using data from the national rare diseases registry in Italy 201
The immunobiology of female predominance in primary biliary cholangitis 197
Fibrocystic liver disease 197
Non-invasive imaging biomarkers in chronic liver disease 192
An update on novel pharmacological agents for primary sclerosing cholangitis 181
Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat 177
Comment on "Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis" 175
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis 174
LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary Cholangitis 172
European Society for Organ Transplantation (ESOT) Consensus Statement on Outcome Measures in Liver Transplantation According to Value-Based Health Care 168
The Role of Epigenetics in Primary Biliary Cholangitis 162
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis 158
A Smooth Esophageal Stricture Causing Dysphagia 156
The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing Cholangitis 153
Geoepidemiology and (epi-)genetics in primary biliary cholangitis 149
Individualizing Care: Management Beyond Medical Therapy 149
EFFICACY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS-AUTOIMMUNE HEPATITIS OVERLAP PATIENTS WITH PERSISTENTLY ELEVATED TRANSAMINASES DESPITE IMMUNOSUPPRESSION 143
Takayasu arteritis and primary sclerosing cholangitis: A casual association or different phenotypes of the same disease? 143
Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 141
Prevalence of upper gastrointestinal endoscopic findings in the community: A systematic review of studies in unselected samples of subjects 135
Pre-treatment risk stratification in primary biliary cholangitis: A predictive model to guide first-line combination therapy 129
Systematic review-Pancreatic involvement in inflammatory bowel disease 128
Antioxidant treatment for acute pancreatitis 127
Glycomic analysis of antibody indicates distinctive glycosylation profile in patients with autoimmune cholangitis 123
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis 120
Diagnostic Yield of Whole Exome Sequencing in Adult-onset Cholestatic Liver Disease 120
Primary Sclerosing Cholangitis 110
Transient elastography in chronic liver disease: beware to the cut-offs! 104
Individualizing Care: Management Beyond Medical Therapy 99
Cluster analysis reveals the prognostic role of serum albumin within the normal range in patients with primary biliary cholangitis 97
Anti-gp210 and other anti-nuclear pore complex autoantibodies in primary biliary cholangitis: What we know and what we should know 97
Elastography in Autoimmune Liver Diseases 91
Clustering Reveals the Prognostic Role of Serum Albumin Values Within the Normal Range in Patients with Primary Biliary Cholangitis 63
Totale 14.683
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.825
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.825
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021222 0 0 0 0 0 0 0 0 0 0 115 107
2021/2022772 100 98 140 80 43 41 14 42 39 32 53 90
2022/20231.439 118 329 125 93 152 181 108 69 101 47 76 40
2023/20241.363 45 65 67 134 145 271 181 28 69 98 45 215
2024/20252.845 195 303 153 143 233 130 191 111 302 421 260 403
2025/20266.376 934 531 494 770 683 346 1.046 309 519 597 147 0
Totale 14.683